Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6T9D

Crystal structure of a bispecific DutaFab in complex with human VEGF121

This is a non-PDB format compatible entry.
Summary for 6T9D
Entry DOI10.2210/pdb6t9d/pdb
DescriptorVP mat DutaFab VH chain, VP mat DutaFab VL chain, Vascular endothelial growth factor A, ... (4 entities in total)
Functional Keywordsmonoclonal antibody, bispecific antibody, fab fragment, vegf, immune system
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains6
Total formula weight122801.39
Authors
Kimbung, R.,Logan, D.T.,Beckmann, R.,Jensen, K.,Speck, J.,Fenn, S.,Kettenberger, H. (deposition date: 2019-10-28, release date: 2020-12-16, Last modification date: 2024-11-13)
Primary citationBeckmann, R.,Jensen, K.,Fenn, S.,Speck, J.,Krause, K.,Meier, A.,Roth, M.,Fauser, S.,Kimbung, R.,Logan, D.T.,Steegmaier, M.,Kettenberger, H.
DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneously.
Nat Commun, 12:708-708, 2021
Cited by
PubMed Abstract: We report the development of a platform of dual targeting Fab (DutaFab) molecules, which comprise two spatially separated and independent binding sites within the human antibody CDR loops: the so-called H-side paratope encompassing HCDR1, HCDR3 and LCDR2, and the L-side paratope encompassing LCDR1, LCDR3 and HCDR2. Both paratopes can be independently selected and combined into the desired bispecific DutaFabs in a modular manner. X-ray crystal structures illustrate that DutaFabs are able to bind two target molecules simultaneously at the same Fv region comprising a VH-VL heterodimer. In the present study, this platform is applied to generate DutaFabs specific for VEGFA and PDGF-BB, which show high affinities, physico-chemical stability and solubility, as well as superior efficacy over anti-VEGF monotherapy in vivo. These molecules exemplify the usefulness of DutaFabs as a distinct class of antibody therapeutics, which is currently being evaluated in patients.
PubMed: 33514724
DOI: 10.1038/s41467-021-20949-3
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.905 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon